Company / Cash per Share
Larimar Therapeutics, Inc. Cash per Share History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.73
FY2019
5-year range
$0.73 / $2.13
FY2015-FY2019
Trend
-59.3%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has fluctuated over the past 6 years, ranging from $0.73 in FY2019 to $13.62 in FY2014.
Based on SEC 10-K filings.
0.73 in FY2019 with a 5-year CAGR of -44.3%.
Declined from $1.30 to $0.73 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -30.1%
- 5-Year CAGR
- -44.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, cash per share decreased 59.3% year-over-year.
- Peak cash per share was recorded in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $0.73 | -59.3% |
| FY2018 | $1.79 | +37.8% |
| FY2017 | $1.30 | -38.9% |
| FY2016 | $2.13 | +37.4% |
| FY2015 | $1.55 | -88.6% |
| FY2014 | $13.62 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026